Page last updated: 2024-11-05

pyridine n-oxide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Pyridine N-oxide is a heterocyclic compound with a nitrogen atom directly bonded to an oxygen atom. It is a colorless solid with a pungent odor. It is synthesized by the oxidation of pyridine with a variety of oxidizing agents, such as hydrogen peroxide or peracids. Pyridine N-oxide is a versatile reagent used in organic synthesis and is particularly valuable for its ability to act as a nucleophile and electrophile. Its importance lies in its role as a precursor to various pharmaceuticals and agrochemicals. It is studied because of its interesting chemical properties and its potential applications in diverse fields like medicine, agriculture, and materials science. '

pyridine N-oxide: RN given refers to parent cpd [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

pyridine N-oxide : The pyridine N-oxide derived from the parent pyridine. It is a drug metabolite of the antihypertensive agent pinacidil. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID12753
CHEMBL ID3278446
CHEBI ID29136
MeSH IDM0060832

Synonyms (49)

Synonym
1-oxido-pyridin-1-ium
AKOS015833456
pyridine, 1-oxide
AC-907/25014058
einecs 211-774-6
ai3-60066
nsc 18250
pyridine oxide
nsc18250
pyridine n-oxide
694-59-7
nsc-18250
pyridine 1-oxide
py n-oxide
CHEBI:29136 ,
1-oxidopyridin-1-ium
pyridine-n-oxide
pyridine-1-oxide
pyridine n-oxide, 95%
P0557
1-oxidanidylpyridin-1-ium
A836503
STL283924
FT-0674188
unii-91f12jjj4h
91f12jjj4h ,
FT-0632826
pyridine 1-oxide [mi]
BP-30184
CHEMBL3278446
ILVXOBCQQYKLDS-UHFFFAOYSA-N
pyridine-oxide
DTXSID3061007
STR00435
pyridin-1-ium-1-olate
mfcd00006194
J-524098
F0001-1803
CS-W001230
Q287787
pyridineoxide
F20317
BCP10416
1-oxidepyridine
10.14272/ILVXOBCQQYKLDS-UHFFFAOYSA-N.1
doi:10.14272/ilvxobcqqyklds-uhfffaoysa-n.1
SB52274
EN300-1696783
SY112170

Research Excerpts

Bioavailability

ExcerptReferenceRelevance
" Activated carbon strongly sorbs hydrophobic organic contaminants, thereby reducing their bioavailability and uptake in organisms."( Exceptionally strong sorption of infochemicals to activated carbon reduces their bioavailability to fish.
Jonker, MT; van Mourik, L, 2014
)
0.4
" The discovery of potent FXIa inhibitors with good oral bioavailability has been challenging."( Discovery of Potent and Orally Bioavailable Pyridine N-Oxide-Based Factor XIa Inhibitors through Exploiting Nonclassical Interactions.
Bruinzeel, W; Cedervall, PE; Chintala, M; DesJarlais, RL; Devine, ZH; Du, F; Gaul, MD; Li, Q; Liu, Z; Lu, T; Macielag, MJ; Milligan, CM; Nargund, R; Pietrak, B; Shaffer, P; Silva, J; Spurlino, JC; Steele, RA; Stratton, CF; Szewczuk, LM; Thieu, T; Wang, X; Wong, V; Xu, G; Zhang, J, 2022
)
0.98
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
drug metabolitenull
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
pyridine N-oxides
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID1148664Octanol-water partition coefficient, log P of the compound1978Journal of medicinal chemistry, Nov, Volume: 21, Issue:11
Phosphorus-nitrogen compounds. 22. Synthesis and antitumor activity of arylsulfonylhydrazone analogues.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (113)

TimeframeStudies, This Drug (%)All Drugs %
pre-199011 (9.73)18.7374
1990's7 (6.19)18.2507
2000's32 (28.32)29.6817
2010's54 (47.79)24.3611
2020's9 (7.96)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 53.51

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index53.51 (24.57)
Research Supply Index4.74 (2.92)
Research Growth Index4.99 (4.65)
Search Engine Demand Index84.07 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (53.51)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews3 (2.63%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other111 (97.37%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]